Compound class:
Synthetic organic
Comment: SRI37892 is a small-molecule that was identified as a FZD7 antagonist in a reporter assay screen, but its pharmacology remains to be fully validated [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-(benzimidazol-1-yl)-N-[4-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-1,3-thiazol-2-yl]benzamide |
Database Links ![]() |
|
Specialist databases | |
GPCRdb Ligand | SRI37892 |
Other databases | |
GtoPdb PubChem SID | 381745004 |
PubChem CID | 41550022 |
Search Google for chemical match using the InChIKey | DXSMYUKZPWJQFM-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | DXSMYUKZPWJQFM |
UniChem Compound Search for chemical match using the InChIKey | DXSMYUKZPWJQFM-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DXSMYUKZPWJQFM-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
SRI 37892 (links to external site)
Cat. No. HY-117002 |